To discuss navigating the rapidly changing landscape of ER+/HER2− metastatic breast cancer (mBC), AMCP Market Insights virtually convened an expert panel of managed care stakeholders in February 2025.
Best Practice Handout - Health Plan Best Practice – Chronic Lymphocytic Leukemia (CLL)
Chronic lymphocytic leukemia (CLL) is a chronic lymphoproliferative disorder (lymphoid neoplasm). It is characterized by a progressive accumulation of functionally incompetent B lymphocytes, which are usually monoclonal in origin. View the fact sheet on JMCP that includes:
- Current Recommended Treatments in CLL
- What Oncology Specialists Recommend Various First-Line CLL Treatments
- Suggested Treatment Algorithm in Patients Intolerant of 1st Generation BTK Inhibitor
- Important Factors to Consider when Calculating the Total Cost of Care for CLL
- Suggested CLL/SLL Treatment Pathways
For more disease state research, view the Market Insights Program.
Related
To discuss managed care approaches to bsAbs with a focus on FL and DLBCL, AMCP Market Insights virtually convened an expert panel of managed care stakeholders in April 2025.
Read the Journal of Managed Care + Specialty Pharmacy (JMCP) - November 2025 Issue
Featured News & Resources
See Full Calendar
Other Events
Award Applications Open
Webinars
AMCP eLearning Day: Nexus Encore
National Meetings
AMCP 2026 Registration Opens
Upcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
